Blueprint Medicines Corporation
BPMC · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | -$50 | -$56 | -$50 |
| Dep. & Amort. | $1 | $4 | $4 | $4 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $29 | $28 | $28 | $28 |
| Change in WC | $0 | -$10 | $15 | -$27 |
| Other Non-Cash | -$85 | -$2 | -$5 | -$3 |
| Operating Cash Flow | -$54 | -$29 | -$14 | -$48 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$1 | -$0 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$283 | -$210 | -$201 | -$355 |
| Inv. Sales/Matur. | $350 | $244 | $231 | $170 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $65 | $34 | $30 | -$188 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $1 | $0 | $147 |
| Stock Issued | $0 | $0 | -$99 | $31 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | $9 | $18 | $31 |
| Financing Cash Flow | $9 | $10 | $18 | $178 |
| Forex Effect | $1 | -$1 | $1 | -$0 |
| Net Chg. in Cash | $20 | $13 | $46 | -$59 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $114 | $101 | $55 | $113 |
| End Cash | $134 | $114 | $101 | $55 |
| Free Cash Flow | -$56 | -$30 | -$14 | -$51 |